To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305

A Phase I, Open, Randomised, Single-Centre, Crossover Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) After Oral and Intravenous Administration of 14C-labelled and Non-labelled AZD1305 to Healthy Male Volunteers

The purpose of this study is to learn more about how AZD1305 is handled by the body, i.e the absorption, distribution, metabolism and excretion of AZD1305.

Inclusion Criteria:

• Healthy volunteers
• A body mass index (BMI=weight/height2) of 19 to 30 kg/m2

Exclusion Criteria:

• Potassium outside normal reference values
• ECG findings outside normal range